BioAdaptives, Inc. (BDPT)

BioAdaptives Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0.02	0.02	0.01	0.03	0.02	0.02
Revenue Growth (YoY)	3424.74%	44.27%	-55.65%	66.31%	-13.15%	21.13%
Cost of Revenue	0.01	0.01	0.09	0.02	0.01	0.01
Gross Profit	0.02	0.01	-0.08	0.01	0.01	0.01
Selling, General & Admin	1	1.05	0.5	0.21	0.37	0.35
Amortization of Goodwill & Intangibles	0	0	0	0.03	0.06	0.13
Operating Expenses	1.01	1.05	0.51	0.24	0.43	0.65
Operating Income	-0.99	-1.04	-0.58	-0.23	-0.42	-0.64
Interest Expense	-0.15	-0.07	-0.09	-0.16	-0.29	-0.27
Other Non Operating Income (Expenses)	-0.47	-0.58	-0.21	-0.31	-0.18	-0.09
EBT Excluding Unusual Items	-1.61	-1.69	-0.88	-0.7	-0.9	-1
Gain (Loss) on Sale of Investments	-	-	-	-0	-0	-0
Asset Writedown	-	-	-0.02	-	-	-
Other Unusual Items	0.13	0.13	-	-0.01	-	-0.05
Pretax Income	-1.47	-1.56	-0.9	-0.71	-0.9	-1.05
Earnings From Continuing Operations	-1.47	-1.56	-0.9	-0.71	-0.9	-1.05
Net Income	-1.47	-1.56	-0.9	-0.71	-0.9	-1.05
Net Income to Common	-1.47	-1.56	-0.9	-0.71	-0.9	-1.05
Shares Outstanding (Basic)	11	10	8	6	1	0
Shares Outstanding (Diluted)	11	10	8	6	1	0
Shares Change (YoY)	26.42%	22.61%	37.57%	744.97%	214.17%	65.51%
EPS (Basic)	-0.14	-0.15	-0.11	-0.12	-1.27	-4.67
EPS (Diluted)	-0.14	-0.15	-0.11	-0.12	-1.27	-4.67
Free Cash Flow	-0.52	-0.53	-0.25	-0.22	-0.23	-0.16
Free Cash Flow Per Share	-0.05	-0.05	-0.03	-0.04	-0.32	-0.70
Gross Margin	69.81%	68.37%	-	37.88%	41.49%	51.10%
Operating Margin	-4166.29%	-5701.79%	-4610.39%	-801.40%	-2456.33%	-3216.43%
Profit Margin	-6186.31%	-8523.35%	-7097.33%	-2494.19%	-5214.08%	-5309.20%
Free Cash Flow Margin	-2189.64%	-2921.68%	-1969.51%	-783.38%	-1323.12%	-802.24%
EBITDA	-0.99	-1.04	-0.58	-0.2	-0.36	-0.5
D&A For EBITDA	0.01	0	0	0.03	0.06	0.13
EBIT	-0.99	-1.04	-0.58	-0.23	-0.42	-0.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.